Manabe S
Nihon Geka Gakkai Zasshi. 1986 Feb;87(2):220-30.
Protein C(PC) is the zymogen of a serine protease which regulates blood coagulation by inactivating activated blood coagulation factors V and VIII. We investigated the plasma level of PC in patients with deep vein thrombosis (DVT, n = 50), Buerger's disease (n = 34), arteriosclerosis obliterans (n = 37) and myocardial infarction (n = 17). PC in plasma was determined by rocket immunoelectrophoresis using a monospecific anti-PC antiserum raised in rabbits. Our study indicated that only in DVT the level of PC was decreased in comparison with the normal control (p less than 0.05). This decrease may be accounted for by increased utilization of PC for the regulation of continuously activated blood coagulation mechanism possibly ongoing in patients with DVT. On the other hand, among the patients with the DVT, we found a homozygous PC deficiency combined with a heterozygous dysplasminogenemia in a 22-year old male who had been suffering from recurrent venous thrombosis since the age of 14. Although the homozygous form of PC deficiency has been reported to be closely associated with fatal thrombotic disorders including purpura furminans during the neonatal period, the patient reported here had surprisingly survived the neonatal period and the childhood without any clinical manifestation relevant to thrombosis.
蛋白C(PC)是一种丝氨酸蛋白酶的酶原,它通过使活化的凝血因子V和VIII失活来调节血液凝固。我们研究了深静脉血栓形成(DVT,n = 50)、血栓闭塞性脉管炎(n = 34)、动脉硬化闭塞症(n = 37)和心肌梗死(n = 17)患者的血浆PC水平。使用在兔体内产生的单特异性抗PC抗血清,通过火箭免疫电泳法测定血浆中的PC。我们的研究表明,只有DVT患者的PC水平与正常对照组相比有所降低(p < 0.05)。这种降低可能是由于DVT患者可能持续存在的活化凝血机制不断激活,导致PC的利用增加所致。另一方面,在DVT患者中,我们在一名自14岁起就患有复发性静脉血栓形成的22岁男性患者中发现了纯合子PC缺乏症合并杂合子异常纤溶酶原血症。尽管据报道纯合子形式的PC缺乏症与包括新生儿期暴发性紫癜在内的致命血栓性疾病密切相关,但此处报道的患者在新生儿期和儿童期均令人惊讶地存活下来,没有任何与血栓形成相关的临床表现。